Search all trials

Find therapies in clinical trials near you – page 61

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Biliary neoplasm+1

Not recruiting

Registered drug

Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Epilepsy

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

Registered drugNo placebo

France

Participants:0–17 years
Substances:Perampanel

Contact Research Centre

B-cell lymphoma+1

Not recruiting

Registered drugNo placebo

Study of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Non-small cell lung cancer stage IV+1

Not recruiting

Registered drugNo placebo

Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-obstructive cardiomyopathy

Not recruiting

Investigational

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Investigational

France

Participants:18–64 years · 65+ years
Substances:Mavacamten

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Erdafitinib

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drug

Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Niraparib Tosilate Monohydrate

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Mitomycin

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

InvestigationalNo placebo

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Follicular lymphoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study on the Effects of Ezabenlimab and BI 907828 in Adult Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ezabenlimab

Contact Research Centre

Find therapies in clinical trials near you – page 61

865 trials match your criteria

Biliary neoplasm+1

Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

Epilepsy

Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

B-cell lymphoma+1

Study of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant

Non-small cell lung cancer stage IV+1

Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

Non-obstructive cardiomyopathy

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Dermatitis atopic

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Bladder transitional cell carcinoma

Study of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy

Ovarian cancer

Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

Bladder cancer

Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

Follicular lymphoma

Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

Neoplasm malignant

Study on the Effects of Ezabenlimab and BI 907828 in Adult Patients with Advanced or Metastatic Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.